Investigación local. Conexiones humanas. WCR Miami Lakes (786) 483-7856
Volver a buscar estudiosNCT07681115
ReclutandoNCT07681115Registro de ClinicalTrials.gov

An Investigation of the Effect of Vitamin D Level During Frozen Embryo Transfer (FET) in IVF and Pregnancy Outcomes

Vitamin D Insufficiency · In Vitro Fertilization and Embryo Transfer

LO ESENCIAL

De qué trata este estudio

El registro indica que este estudio recluta participantes. La disponibilidad puede variar por centro.

Tipo de estudio
Observacional
Fase
No aplica / no indicada
Rango de edad
18 años - 40 años
Sexo admitido
Femenino
Voluntarios sanos
No aceptados
Participantes
126 Estimado

Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.

Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.

Acerca de la investigación

Vitamin D is best known for keeping our bones healthy, but growing research suggests it may also play a role in fertility. Many In vitro fertilization (IVF) clinics now routinely check vitamin D levels and prescribe supplements before treatment, but the science is still unclear on whether this actually improves the chances of pregnancy.

Our study, based in the United Arab Emirates (UAE), aims to find out whether a woman's vitamin D level on the day of her frozen embryo transfer (FET) makes a difference to whether she becomes pregnant and delivers a baby. The UAE is an ideal setting for this research, as vitamin D deficiency is particularly common in the region. The findings could shape how fertility clinics screen and treat women seeking fertility treatment in the future.

Leer la descripción completa

Serum vitamin D3 has attracted growing research interest for its potential role in female reproductive physiology. While some studies associate sufficient vitamin D3 levels with improved IVF outcomes, others have failed to confirm this, leaving the evidence base contested. Despite this uncertainty, pre-In vitro fertilization (IVF) vitamin D screening and supplementation of insufficient patients has become widespread clinical practice. Evidence specific to frozen embryo transfer (FET) cycles remains particularly limited. Recent prospective studies found no significant difference in ongoing pregnancy, live birth, or implantation rates between vitamin D3-insufficient women receiving supplementation and vitamin D3-replete women who did not, underscoring the need for higher-quality, targeted research. While emerging data support a role for vitamin D in endometrial receptivity, it remains unclear whether correcting insufficiency prior to FET meaningfully improves reproductive success.

To address these gaps, our study will evaluate the association between serum vitamin D3 levels on the day of FET and subsequent pregnancy and delivery outcomes at a UAE fertility center. Supplementation history and relevant clinical variables will be captured via patient questionnaire. Vitamin D status will be classified per International Society of Endocrinology guidance: deficient (\<20 ng/mL), insufficient (20-29 ng/mL), and sufficient (≥30 ng/mL). Given the high regional prevalence of vitamin D deficiency, this study is well-positioned to determine whether vitamin D status represents a modifiable determinant of reproductive success, with direct implications for clinical screening and management protocols in this population.

¿Quién podría participar?

La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.

Inclusion:

  • Women undergoing frozen embryo transfer (FET) at Fakih IVF.
  • Age between 18 and 40 years.
  • Body mass index (BMI) between 18 and 40 kg/m².
  • Patients who had serum vitamin D levels assessed within three months prior to FET
  • Supplementation with Vitamin D if deficient \< 30 ng/mL (75 nmol/L).

Exclusion:

  • Age below 18 years or above 40 years.
  • BMI below 18 kg/m² or above 40 kg/m².
  • Patients who did not have vitamin D levels measured within three months prior to FET.
  • Patients who were found to have low vitamin D levels but did not receive supplementation.
  • Patients with recurrent implantation failure (RIF).
  • Patients with known uterine factors affecting implantation (e.g., congenital uterine anomalies, intrauterine adhesions, submucosal fibroids).
  • Patients with significant medical comorbidities that may affect pregnancy outcomes.

Población del estudio

Women undergoing FET cycle who do not suffer from conditions affecting implantation and have got vitamin D levels tested 3 - 6 months before FET cycle.

Entiende la evaluación inicial

Tratamiento, grupos y participación

El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.

Asignación
No informado
Enmascaramiento
No informado
Women undergoing frozen embryo transfer (FET) at Fakih IVF

The study will enroll women aged 18-40 years with a BMI of 18-40 kg/m² undergoing FET at Fakih IVF, who had serum vitamin D assessed within three months prior to transfer. Women with deficient levels (\<30 ng/mL) must have received supplementation prior to FET to be eligible.

Exclusions are designed to reduce confounding: women are excluded if vitamin D was not measured within the required window, if identified deficiency went untreated, or if they have a history of recurrent implantation failure (RIF). Women with uterine factors known to impair implantation including congenital anomalies, intrauterine adhesions, or submucosal fibroids are also excluded, as are those with significant medical comorbidities that may independently affect pregnancy outcomes.

Other: No Intervention: Observational Cohort

No Intervention: Observational Cohort OTHER

There are no interventions in this study. This is an observational cohort study.

Prepara tus preguntas

Qué evalúan los investigadores

Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.

Medidas principales

Concentration of serum 25-hydroxyvitamin D levels measured on the day of FET

Plazo: Vitamin D level tested on the day of FET.

No informado en este registro.

Clinical pregnancy test

Plazo: From enrollment on day of FET to 1 month post FET

No informado en este registro.

Medidas secundarias

Live birth rate, miscarriage rate, and preterm birth rate.

Plazo: From enrollment to six weeks post partum

No informado en este registro.

El registro no indica resultados publicados.

Revisa las tablas completas y sus limitaciones en el registro oficial.

Abrir resultados oficiales ↗

Centros de investigación (2)

El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.

2 centros

Fakih IVF Fertility Centre LLCAbu Dhabi, United Arab EmiratesReclutando
Dr. Lamiya Mohiyiddeen, MD, FRCOGCONTACTlamiya.mohiyiddeen@fakihivf.com+971543676002
Michael Fakih, MDPRINCIPAL_INVESTIGATOR
Yasmin Sajjad, MD, FRCOG, DOWHPRINCIPAL_INVESTIGATOR
Lamiya Mohiyiddeen, MD, FRCOGPRINCIPAL_INVESTIGATOR
Ver ubicación en el mapa ↗
First IVF Fertility CentreAbu Dhabi, United Arab EmiratesReclutando
Yasmin Sajjad, MD, FRCOG, DOWHPRINCIPAL_INVESTIGATOR
Ver ubicación en el mapa ↗

Equipo y fechas

Patrocinador principal
Fakih IVF Fertility Center
Inicio del estudio
1 jun 2026 Real
Finalización primaria
2027-06 Estimado
Finalización del estudio
2027-08 Estimado
Primera publicación
2 jul 2026 Real
Última actualización
10 nov 2026 Real

Contactos oficiales del estudio

Dr. Lamiya Mohiyiddeen, MD, FRCOGCONTACTlamiya.mohiyiddeen@fakihivf.com+971543676002
Título oficial del estudio

Vitamin D Levels and Pregnancy Outcomes Following Frozen Embryo Transfer (FET) in the UAE

EL PRÓXIMO PASO, CON APOYO HUMANO

Consulta a Wellness Clinical Research

Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.

No incluyas expedientes médicos, diagnósticos, medicamentos, números de seguro ni otros datos sensibles. Este formulario es para preguntas generales, no para atención urgente.

Enviar una pregunta no te inscribe en un estudio.

Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.

Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026